Evidence map›Paper›PMID 21508260›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

Dual protective mechanisms of matrix metalloproteinases 2 and 9 in immune defense against Streptococcus pneumoniae.

Jeong-Soo Hong, Kendra J Greenlee, Ramanan Pitchumani, Seung-Hyo Lee, Li-zhen Song, Ming Shan, Seon Hee Chang, Pyong Woo Park, Chen Dong, Zena Werb and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Frontiers in cellular and infection microbiology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. VBEBioMedicine · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Jeong-Soo HongSection of Pulmonary and Critical Care, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Kendra J Greenlee
Ramanan Pitchumani
Seung-Hyo Lee
Li-zhen Song
Ming Shan
Seon Hee Chang
Pyong Woo Park
Chen Dong
Zena Werb
Akhil Bidani
David B Corry
Farrah Kheradmand
Baylor College of Medicine · USThe University of Texas MD Anderson Cancer Center · USUniversity of Houston · USBoston Children's Hospital · USKorea Advanced Institute of Science and Technology · KRMichael E. DeBakey VA Medical Center · USUniversity of California, San Francisco · US

Funding

Sulfs and Injury Repair in Mucosal EpitheliaP01AI053194 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WERB, ZENA · 2002 to 2012
$13.4M
The Role of Proteinases in Experimental AsthmaU19AI070973 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI EISSA, N. TONY · 2006 to 2010
$6.7M
Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Viral-induced T Cell Responses in COPD ExacerbationR01HL082487 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KHERADMAND, FARRAH · 2005 to 2009
$2.6M
Immune Modulators of Inflammation in Severe COPDR01HL072419 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI KHERADMAND, FARRAH · 2002 to 2010
$1.9M
Adhesion Molecules in Allergic Lung InflammationR01AI057696 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2005 to 2009
$1.6M
Airway Epithelial Control of Allergic Lung InflammationK02HL075243 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2004 to 2008
$506k
NHLBI NIH HHS HL075243NHLBI NIH HHS HL082487NHLBI NIH HHS HL72419NHLBI NIH HHS K02 HL075243NHLBI NIH HHS R01 HL072419NHLBI NIH HHS R01 HL082487NIAID NIH HHS AI053831NIAID NIH HHS AI057696NIAID NIH HHS AI070973NIAID NIH HHS P01 AI053194NIAID NIH HHS R01 AI057696NIAID NIH HHS T32 AI053831NIAID NIH HHS U19 AI070973
6 · The paper itself

Abstract

A localized and effective innate immune response to pathogenic bacterial invasion is central to host survival. Identification of the critical local innate mediators of lung defense against such pathogens is essential for a complete understanding of the mechanism(s) underlying effective host defense. In an acute model of Streptococcus pneumoniae lung infection, deficiency in matrix metalloproteinase (MMP)2 and MMP9 (Mmp2/9(-/-)) conferred a survival disadvantage relative to wild-type mice treated under the same conditions. S. pneumoniae-infected Mmp2/9(-/-) mice recruited more polymorphonuclear leukocytes to the lung but had higher bacterial burdens. Mmp2/9(-/-) mice showed significantly higher levels of IL-17A, IP-10, and RANTES in the lung. Although MMP2-dependent cleavage partially inactivated IL-17A, MMP9 was critical for effective bacterial phagocytosis and reactive oxygen species generation in polymorphonuclear neutrophils. These data demonstrate critical nonredundant and protective roles for MMP2 and MMP9 in the early host immune response against S. pneumoniae infection.

Indexed as

AnimalsChemokine CCL5Chemokine CXCL10Host-Pathogen InteractionsImmunity, InnateInterleukin-17Kaplan-Meier EstimateMatrix Metalloproteinase 2Matrix Metalloproteinase 9MiceMice, Inbred C57BLMice, KnockoutNeutrophilsPhagocytosisPneumococcal InfectionsPneumoniaChemokine CCL5Chemokine CXCL10Interleukin-17Matrix Metalloproteinase 2Matrix Metalloproteinase 9Reactive Oxygen Species

Identifiers

PMID21508260
PMCPMC3546495
OpenAlexW1798158436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.